SCHEMBL20042726

SCHEMBL20042726

Cc1nc(O)c2c(n1)CN(C(=O)c1cccc(Cl)c1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.45
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
P2RX7 Q99572 1/20 0.44
GRM5 P41594 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
HSD11B1 P28845 1/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MGLL Q99685 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042749 0.85 PKM (0.43) PKMALDH1A1L3MBTL1P2RX7GRM5
SCHEMBL20042744 0.85 MTHFD2 (0.44) P2RX7GRM5
SCHEMBL20042771 0.83 P2RX7 (0.47) PKMALDH1A1L3MBTL1P2RX7GRM5
SCHEMBL20042739 0.80 P2RX7 (0.44) PKMALDH1A1L3MBTL1P2RX7GRM5
SCHEMBL20042737 0.80 P2RX7 (0.44) PKMALDH1A1L3MBTL1P2RX7GRM5
SCHEMBL20042732 0.80 P2RX7 (0.44) PKMALDH1A1L3MBTL1P2RX7GRM5
SCHEMBL20042734 0.77 P2RX7 (0.47) ALDH1A1P2RX7GRM5
SCHEMBL20042684 0.72 SMN1; SMN2 (0.52) ALDH1A1P2RX7GRM5CYP1A2CYP3A4
SCHEMBL20042668 0.71 HPGD (0.51) ALDH1A1L3MBTL1P2RX7GRM5CYP3A4
SCHEMBL20042689 0.71 P2RX7 (0.39) P2RX7GRM5CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed